retatrutide phase 3 trial results just delivered the most powerful weight loss data ever recorded in a obesity trial. At 104 weeks, participants on the 12 mg dose lost an average of 85 pounds π¨ HOT OFF THE PRESS:
Description
Weeks 5 to 8: Fine-tune
Just like how some people seem unable to lose weight on Ozempic, some people are seemingly unaffected by SSRIs
A February 2026 study in the Journal of Clinical Endocrinology & Metabolism found an 11% higher fragility fracture risk in older adults with Type 2 diabetes using GLP-1 medications versus those using other diabetes medications - though this was a retrospective study documenting association, not proven causation
According to the brand's published materials, NativePath recommends a minimum 90-day consistent use window to assess individual response
McHenry, Jenna et al
